CVE security advisories and vulnerability history for dna by Valmet.
Last updated
Valmet dna has 2 published CVE records since 2022, of which 0 are in CISA's Known Exploited Vulnerabilities catalog and 0 have a known public exploit. The average CVSS base score across scored CVEs is 8.8.
This page aggregates every publicly disclosed vulnerability (CVE) affecting Valmet dna, with a severity breakdown, the affected and patched versions, the most common weakness types, and the full CVE list.
How the CVSS severity of Valmet dna's CVEs breaks down, plus how many are exploited in the wild or have public exploit code.
In CISA’s Known Exploited Vulnerabilities catalog
0
None of Valmet dna's CVEs are currently listed in CISA's KEV catalog.
Public exploits
0
No Valmet dna CVEs currently have a tracked public exploit.
Browse every Valmet dna version named in a CVE, then pick one to see only the CVEs that affect it.
2 CVEs
The CWE weakness categories most often found in Valmet dna CVEs. Follow any weakness for its full explanation.
How many Valmet dna CVEs were published each year.
Browse vulnerabilities for other products by Valmet.
Common questions about Valmet dna vulnerabilities.
Vulnerability data is sourced from the CVE Program; severity, KEV, and exploit signals are aggregated by RadicalNotion.AI.
Monitor new Valmet dna vulnerabilities as they are disclosed, with AI-written analysis and remediation guidance.
